Transgenomic (TBIO), Precipio Diagnostics Enter Merger Agreement
Tweet Send to a Friend
Transgenomic, Inc. (Nasdaq: TBIO), and privately-held Precipio Diagnostics, LLC, announced entry into a merger agreement, pursuant to which Precipio will ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE